Showing 1 - 8 results of 8 for search 'Su-ning Chen', query time: 0.04s Refine Results
  1. 1
    Case Report: Off-label treatment of idiopathic hypereosinophilic syndrome with Omalizumab

    Case Report: Off-label treatment of idiopathic hypereosinophilic syndrome with Omalizumab by Zhiyu Zhang, Zhiyu Zhang, Zhiyu Zhang, Yingxin Sun, Yingxin Sun, Yingxin Sun, Su-Ning Chen, Su-Ning Chen, Su-Ning Chen

    Published 2023-06-01
    Get full text
    Article
  2. 2
    A Recurrent Cryptic MED14-HOXA9 Rearrangement in an Adult Patient With Mixed-Phenotype Acute Leukemia, T/myeloid, NOS

    A Recurrent Cryptic MED14-HOXA9 Rearrangement in an Adult Patient With Mixed-Phenotype Acute Leukemia, T/myeloid, NOS by Qian Wang, Ling Zhang, Ming-qing Zhu, Zhao Zeng, Bao-zhi Fang, Jun-dan Xie, Jin-lan Pan, Chun-xiao Wu, Ni Wu, Ri Zhang, Su-ning Chen, Su-ning Chen, Hai-ping Dai, Hai-ping Dai

    Published 2021-07-01
    Get full text
    Article
  3. 3
    Effective treatment with Gilteritinib-based regimens for FLT3-mutant extramedullary relapse in acute promyelocytic leukemia

    Effective treatment with Gilteritinib-based regimens for FLT3-mutant extramedullary relapse in acute promyelocytic leukemia by Chun-xiao Hou, Yu Chen, Shan-hao Liu, Yi-zhi Jiang, Dong-ping Huang, Su-ning Chen

    Published 2024-12-01
    Get full text
    Article
  4. 4
    MiR-130a is aberrantly overexpressed in adult acute myeloid leukemia with t(8;21) and its suppression induces AML cell death

    MiR-130a is aberrantly overexpressed in adult acute myeloid leukemia with t(8;21) and its suppression induces AML cell death by Chao Ding, Su-Ning Chen, Roderick A. F. Macleod, Hans G. Drexler, Stefan Nagel, De-Pei Wu, Ai-Ning Sun, Hai-Ping Dai

    Published 2018-01-01
    Get full text
    Article
  5. 5
    Efficacy of ruxolitinib in a patient with myelodysplastic/myeloproliferative neoplasm unclassifiable and co-mutated JAK2, SF3B1 and TP53

    Efficacy of ruxolitinib in a patient with myelodysplastic/myeloproliferative neoplasm unclassifiable and co-mutated JAK2, SF3B1 and TP53 by Qian Wang, Hai-ping Dai, Dan-dan Liu, Jun-dan Xie, Hong Yao, Zi-xuan Ding, Ting-ting Tao, Su-ning Chen, Ri Zhang

    Published 2020-01-01
    Get full text
    Article
  6. 6
    Characterizing the Molecular Abnormalities in Rare De Novo Ph+ Acute Myeloid Leukemia

    Characterizing the Molecular Abnormalities in Rare De Novo Ph+ Acute Myeloid Leukemia by Hong-Ying Chao, Guang-Ying Sheng, Xiu-Wen Zhang, Min Zhou, Hong-Jie Shen, Su-Ning Chen, Jian-Nong Cen, Yi-Wu Sun, Tao Chen, Xu-Zhang Lu, Ri Zhang

    Published 2018-01-01
    Get full text
    Article
  7. 7
    A Phase II Trial of the Double Epigenetic Priming Regimen Including Chidamide and Decitabine for Relapsed/Refractory Acute Myeloid Leukemia

    A Phase II Trial of the Double Epigenetic Priming Regimen Including Chidamide and Decitabine for Relapsed/Refractory Acute Myeloid Leukemia by Jia Yin, Jia Yin, Chao-Ling Wan, Chao-Ling Wan, Ling Zhang, Ling Zhang, Hao Zhang, Lian Bai, Hai-Xia Zhou, Hai-Xia Zhou, Ming-Zhu Xu, Ming-Zhu Xu, Li-Yun Chen, Li-Yun Chen, Chong-Sheng Qian, Chong-Sheng Qian, Hui-Ying Qiu, Hui-Ying Qiu, Su-Ning Chen, Su-Ning Chen, Xiao-Wen Tang, Xiao-Wen Tang, De-Pei Wu, De-Pei Wu, Yan-Ming Zhang, Ai-Ning Sun, Ai-Ning Sun, Sheng-Li Xue, Sheng-Li Xue

    Published 2021-09-01
    Get full text
    Article
  8. 8
    Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemia

    Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemia by Ya-Fang Ma, Ying Lu, Qian Wu, Yin-Jun Lou, Min Yang, Jie-Yu Xu, Cai-Hong Sun, Li-Ping Mao, Gai-Xiang Xu, Li Li, Jian Huang, Huai-Yu Wang, Li-Jiang Lou, Hai-Tao Meng, Jie-Jing Qian, Wen-Juan Yu, Ju-Ying Wei, Zhen-Yu Li, Xue-Lu Zhu, Xiao-Yan Yan, Su-Ning Chen, Jie Jin, Hong-Hu Zhu

    Published 2022-10-01
    Get full text
    Article

Search Tools: